PCR-dipstick as a Point-of-Care Diagnostic Test for COVID-19

Current nucleic acid based tests for active COVID-19 infection require expensive laboratory equipment that are only suited to large, centralized diagnostic laboratories. Using the grant funding, Dr.  Wu’s team will develop a simple, cheap and rapid test based on the PCR-dipstick technology. If successful, this new test can be deployed widely at the community level for rapid decentralized point-of-care diagnosis and epidemiological surveillance.